Entering Saudi Arabia’s Healthcare Market: What Most Companies Get Wrong
Saudi Arabia is one of the most interesting healthcare markets in the world right now.
There’s real momentum behind Vision 2030, genuine investment going into the system, and a clear appetite for innovation across digital health, diagnostics, biotech and AI.
From the outside, it looks like a big opportunity. And it is. What we find frustrating is that many can have the right solution, the right team and it can be the right time, but still manage to get their market entry approach wrong.
For more than a decade living and working in the region, I’ve spoken to a lot of companies looking at the GCC, and Saudi specifically. Some at a very early stage, others further along, are already working in the region.
The same themes come up again and again.
“We’ll find a distributor and get going.”
“We’re already in the UAE, so this should be similar.”
“Once we’ve sorted registration, we can start selling.”
All reasonable assumptions.
But in most cases, they are already missing the most important elements.
Saudi isn’t just another market you can plug into.
What Saudi is
Saudi is a system-led, relationship-driven environment. How you show up matters just as much as what you’re offering, sometimes more.
Healthcare sits across multiple layers. You’ve got national strategy, health clusters, large private providers, and then a growing innovation ecosystem alongside that.
Each of those groups thinks differently, buys differently, and has different priorities.
If you don’t understand that landscape early on, things tend to stall quite quickly.
A lot of companies also over-focus on regulation.
SFDA, approvals, pathways etc. it’s all important, and it needs to be done properly.
But in reality, regulation is rarely the reason things don’t move forward.
More often, it comes down to a few simple issues:
- The solution isn’t clearly aligned to what the system actually needs
- They’re speaking to the wrong people
- They’re trying to sell too early
- They underestimate how long it takes to build trust
- They haven’t addressed the integation and localisation issues first
That last one is probably the biggest; in Saudi healthcare, trust comes before transactions.
People want to understand who you are, how you operate, whether you’re serious about the region, and whether your solution genuinely solves a problem they care about. I used to talk a lot about this approach being centred around authenticity. I’m moving away from this thinking and more towards sincerity.
Building trust through sincerity doesn’t happen in one meeting. It happens through consistent, structured engagement.
The companies that tend to do well approach things differently.
What successful companies do
Successful companies don’t rush to sell.
They take time upfront to understand the market properly, how decisions are made, who the real stakeholders are, where the demand actually sits. They adapt their positioning so it resonates locally, not just globally. They invest in relationships, not just introductions. And importantly, they’re comfortable starting small.
Pilots are often the right entry point. They allow you to demonstrate value, build credibility, and create something tangible that can scale. Companies often go straight to the big players, but the better places to start are the mid-tier and University hospitals. The bigger players will often start by asking 3 simple questions:
- Are you local? | Translation: Do you have a local entity or partner in the Kingdom where we can contract through?
- Are you compliant? | Translation: Have you gone through the Saudi FDA, Saudi Commission for Health Specialities, the Ministry of Health and got the correct licences?
- What have you done in the Kingdom? | Translation: Your solution might work in another country, but we’re too busy to sort out localisation and integration issues, show me that you’ve proven it works in the Kingdom through a case study, PoC or pilot etc.
Successful companies have figured this out and can confidently say yes to all of the above. For those that have not figured this out, it is here that things usually go wrong, and the tell-tale signs are obvious:
Companies push for commercial conversations too early.
They rely too heavily on a single partner.
They assume interest equals intent.
And they underestimate the need to be present and engaged over time.
That combination almost always leads to frustration and none of this is to say Saudi is difficult. It’s just different.
And for companies that take the time to understand that difference, the opportunity is significant.
There’s scale, there’s investment, and there’s a real willingness to adopt new approaches, particularly where they align with system priorities.
It’s also increasingly becoming a platform to access wider regional markets, the GCC, MENA and beyond. With over 2 billion Muslims around the world, companies plans to scale to Saudi miss the point. Saudi is not just a destination. It’s a launchpad. The mindset shift is the important part.
It’s not about asking “how do we enter quickly?”
It’s about asking “how do we build something credible here?”
Once you approach it that way, things tend to move in the right direction.
At Welcome Health Ventures, this is exactly what we spend our time working on, helping companies move from initial interest to something that actually lands and grows in-market.
Not just getting in, but getting it right.
